DEVICE CATEGORY · NHT
Assay, Nucleic Acid Amplification, Bacillus Anthracis
An invitro diagnostic device used to presumptively detect the presence or absence of b. Anthracis directly in blood specimens or suspicious culture growth.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Centers for Disease Control and Prevention | 510(k) clearance | Oct 7, 2026 | FDA |
Source information
Follow the FDA links to view the original records.
